Integrating Biofilm-Based Fermentation With Continuous Processes for Improved L-Valine Production

IF 3.2 3区 生物学 Q2 BIOCHEMICAL RESEARCH METHODS
Caice Liang, Yong Wang, Shuqi Shi, Alan Yan, Qingguo Liu, Wei Liu, Hui Han, Wenlu Qi, Tianpeng Chen, Wenjun Sun, Yong Chen
{"title":"Integrating Biofilm-Based Fermentation With Continuous Processes for Improved L-Valine Production","authors":"Caice Liang,&nbsp;Yong Wang,&nbsp;Shuqi Shi,&nbsp;Alan Yan,&nbsp;Qingguo Liu,&nbsp;Wei Liu,&nbsp;Hui Han,&nbsp;Wenlu Qi,&nbsp;Tianpeng Chen,&nbsp;Wenjun Sun,&nbsp;Yong Chen","doi":"10.1002/biot.70027","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>L-valine, an essential branched-chain amino acid, is widely used across various industrial sectors. Despite its significance, there is a scarcity of continuous fermentation methodologies, specifically for L-valine production. Biofilm-based Technologies face challenges in sustaining continuous L-valine production due to cell wall damage caused by L-valine sterilization. Here, we combined continuous fermentation principles with Biofilm-based technologies to develop a biofilm-based continuous fermentation (BCF) system, enabling sustained L-valine production. By analyzing the fermentation kinetics of free-cell fermentation (FCF), we optimized the L-valine titer in BCF to 60–70 g/L, achieving a yield of 0.44 g/g glucose—a 10% increase over FCF. Notably, reducing the controlled L-valine titer in BCF extended the fermentation time but simultaneously decreased both the yield and production rate. Conversely, shortening the fermentation time was associated with an increase in both yield and production rate. In summary, BCF significantly improved L-valine purity, yield from glucose, and production rate while reducing by-product formation.</p>\n </div>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 4","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70027","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

L-valine, an essential branched-chain amino acid, is widely used across various industrial sectors. Despite its significance, there is a scarcity of continuous fermentation methodologies, specifically for L-valine production. Biofilm-based Technologies face challenges in sustaining continuous L-valine production due to cell wall damage caused by L-valine sterilization. Here, we combined continuous fermentation principles with Biofilm-based technologies to develop a biofilm-based continuous fermentation (BCF) system, enabling sustained L-valine production. By analyzing the fermentation kinetics of free-cell fermentation (FCF), we optimized the L-valine titer in BCF to 60–70 g/L, achieving a yield of 0.44 g/g glucose—a 10% increase over FCF. Notably, reducing the controlled L-valine titer in BCF extended the fermentation time but simultaneously decreased both the yield and production rate. Conversely, shortening the fermentation time was associated with an increase in both yield and production rate. In summary, BCF significantly improved L-valine purity, yield from glucose, and production rate while reducing by-product formation.

结合生物膜发酵与连续工艺提高l -缬氨酸产量
l -缬氨酸是一种必需的支链氨基酸,广泛应用于各个工业部门。尽管它的重要性,有一个短缺的连续发酵方法,特别是l -缬氨酸生产。基于生物膜的技术在维持l -缬氨酸的连续生产方面面临挑战,因为l -缬氨酸灭菌会导致细胞壁损伤。在这里,我们将连续发酵原理与基于生物膜的技术相结合,开发了一种基于生物膜的连续发酵(BCF)系统,使l -缬氨酸的持续生产成为可能。通过分析自由细胞发酵(FCF)的发酵动力学,我们优化了BCF的L-缬氨酸滴度为60-70 g/L,实现了0.44 g/g葡萄糖的产率,比FCF提高了10%。值得注意的是,降低BCF的控制l -缬氨酸滴度延长了发酵时间,但同时降低了产量和生产率。相反,缩短发酵时间与产量和生产速率的增加有关。总之,BCF显著提高了l -缬氨酸纯度、葡萄糖产率和生产速率,同时减少了副产物的形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biotechnology Journal
Biotechnology Journal Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍: Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances. In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office. BTJ promotes a special emphasis on: Systems Biotechnology Synthetic Biology and Metabolic Engineering Nanobiotechnology and Biomaterials Tissue engineering, Regenerative Medicine and Stem cells Gene Editing, Gene therapy and Immunotherapy Omics technologies Industrial Biotechnology, Biopharmaceuticals and Biocatalysis Bioprocess engineering and Downstream processing Plant Biotechnology Biosafety, Biotech Ethics, Science Communication Methods and Advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信